5-alpha-reductase inhibitors for lower urinary tract symptoms secondary to benign prostatic obstruction

This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the effects of 5-alpha-reductase inhibitors (5ARIs) for treating lower urinary tract symptoms (LUTS) secondary to benign prostatic obstruction (BPO). © 2015 The Cochrane Collaboration.

Detalles Bibliográficos
Autores Principales: "García?Perdomo, Herney A, Lopez, Hugo E, Tacklind, James"
Formato: Artículo (Article)
Lenguaje:Inglés (English)
Publicado: John Wiley and Sons Ltd 2015
Materias:
Acceso en línea:https://repository.urosario.edu.co/handle/10336/23701
https://doi.org/10.1002/14651858.CD011928